# EDGAR Filing Document

**Accession Number:** 0001910053
**File Stem:** 0000000000-25-007006
**Filing Date:** 2025-7
**Character Count:** 3545
**Document Hash:** 00cb020ef1ea94ccc81028235ef31374
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-007006.hdr.sgml**: 20260630

**ACCESSION NUMBER**: 0000000000-25-007006

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250702

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Midori Group Inc.
- **CENTRAL INDEX KEY:** 0001910053
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 024-12526

**BUSINESS ADDRESS:**
- **STREET 1:** 505 BURRARD STREET
- **STREET 2:** SUITE 1570
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V7X 1M5
- **BUSINESS PHONE:** 604-838-6014

**MAIL ADDRESS:**
- **STREET 1:** 505 BURRARD STREET
- **STREET 2:** SUITE 1570
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V7X 1M5

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 1284670 BC Ltd.
- **DATE OF NAME CHANGE:** 20220208
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001493152-24-042441

## Text-Extract

```

                                                            July 2, 2025

Ken Lyons
Chief Executive Officer
Midori Group Inc.
5 Hazelton Avenue, Suite 400
Toronto, ON M5R 2E1

       Re: Midori Group Inc.
           Amendment No. 3 to Offering Statement on Form 1-A
           Filed June 20, 2025
           File No. 024-12526
Dear Ken Lyons:

     We have reviewed your amended offering statement and have the following
comments.

       Please respond to this letter by amending your offering statement and
providing the
requested information. If you do not believe a comment applies to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your offering statement and the
information you
provide in response to this letter, we may have additional comments. Unless we
note
otherwise, any references to prior comments are to comments in our May 5, 2025
letter.

Amendment No. 3 to Offering Statement on Form 1-A
Trends, page 34

1.     We note your revisions in response to prior comment 9 and your
disclosure that
       several of your projects have completed the plant trials and that you
have plant trial
       customers that you expect to launch within the next 6 months. Please
clarify what you
       mean by plant trials in this context and what it means for certain
customers to be plant
       trial customers.
Exhibits

2.     Please refile exhibits 6.1, 6.5 and 12.1 in proper text-searchable
format. They appear
       to have been uploaded as images. For guidance, please refer to Item 301
of Regulation
       S-T.
 July 2, 2025
Page 2

       Please contact Tayyaba Shafique at 202-551-2110 or Michael Fay at
202-551-3812 if
you have questions regarding comments on the financial statements and related
matters. Please contact Nicholas O'Leary at 202-551-4451 or Conlon Danberg at
202-551-
4466 with any other questions.

                                                        Sincerely,

                                                        Division of Corporation
Finance
                                                        Office of Industrial
Applications and
                                                        Services
cc:   Arden Anderson, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._